INS and Alzheimer disease: Overall, the findings in the PPAR-δ null mouse model strongly support the hypothesis that AD neurodegeneration can result from chronic impairments in insulin signaling through PPAR-δ accompanied by progressive increases in AGE, RAGE activity, neuroinflammation, oxidative stress, and Aβ accumulations [45,47].